Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Alliqua Biomedical (ALQA)

Alliqua Biomedical (ALQA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Alliqua Biomedical 2150 CABOT BLVD WEST SUITE B LANGHORNE PA 19047 USA

www.alliqua.com P: 215-702-8550

Description:

Alliqua, Inc. is a biomedical company. The company focused on the development, manufacturing and distribution of proprietary transdermal wound care and drug delivery technologies. Its technology platform produces hydrogels, a 3-dimensional cross-linked network of water soluble polymers. The company's product includes SilverSeal(R) a hydrogel wound dressing with silver coated fibers and Hydress(R) an over-the-counter hydrogel wound dressing. It serves the healthcare industry including wound healing, medical diagnostics and cosmeceuticals. Alliqua, Inc. is headquartered in Langhorne, Pennsylvania.

Key Statistics

Overview:

Market Capitalization, $K 13,447
Shares Outstanding, K 5,005
Annual Sales, $ 2,220 K
Annual Net Income, $ -8,420 K
Last Quarter Sales, $ 130 K
Last Quarter Net Income, $ -870 K
60-Month Beta 2.03
% of Insider Shareholders 13.20%
% of Institutional Shareholders 13.40%
Float, K 4,345
% Float 86.80%

Growth:

1-Year Return 12.41%
3-Year Return -70.15%
5-Year Return -95.94%
5-Year Revenue Growth 23.33%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 05/13/19
Earnings Per Share ttm -0.86
EPS Growth vs. Prev Qtr 69.70%
EPS Growth vs. Prev Year 74.68%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-6 on 05/06/19

ALQA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -71.73%
Return-on-Assets % -55.23%
Profit Margin % -379.28%
Debt/Equity 0.00
Price/Sales 5.51
Price/Cash Flow N/A
Price/Book 1.65
Book Value/Share 1.48
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar